Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : DLB Dolby Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: Cooters who wrote (159)	7/26/2018 12:51:14 PM
From: Cooters	Respond to of 324

In a report released today, James Goss from Barrington assigned a Buy rating to Dolby Laboratories (NYSE: DLB), with a price target of $78. The company’s shares closed yesterday at $64.55. Goss commented: “We continue our OUTPERFORM investment rating on DLB and $78 price target: While the favorable financial impact from the rollout of new technologies continues to evolve, we feel the benefits from some of them are becoming increasingly meaningful. The company’s $0.64 annual dividend provides a yield of 1.0%. The company also is active in repurchasing its shares, with over $400 million in authorization currently remaining. Management has noted that monetization benefits from its cinema sector efforts will not have a material impact on financial metrics for at least a year or two. However, excitement over the early success of these initiatives has created a more optimistic view of Dolby’s potential to create renewed corporate momentum as management continues to target a return to double-digit growth.”